Guiheen Lawrence P. bought ADMA
March 13, 2026 · Form 4 insider transaction
Guiheen Lawrence P. bought 30,000 shares of ADMA Biologics, Inc. at $3.66 per share, a transaction worth $109.8K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
30,000
Price
$3.66
Total value
$109.8K
InsiderGuiheen Lawrence P.
RoleDirector
CompanyADMA Biologics, Inc. (ADMA)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 13, 2026
Filing dateMarch 17, 2026
Shares owned after135,520
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Includes, as of the transaction date, (i) 10,690 RSUs granted on February 9, 2026, which will fully vest on February 9, 2027, subject to the Reporting Person's continued service as of such vesting date; and (ii) 94,830 shares of common stock owned by the Reporting Person.